Pharmaron (HK: 03759) has announced the successful completion of its convertible bond issuance.

The company confirmed that all conditions under the subscription agreement have now been fulfilled, and the issuance of the convertible bonds was finalized on the closing date, which fell on September 2, 2026. On that same day, Pharmaron issued convertible bonds with an aggregate principal amount of RMB 2.18 billion to the subscriber, strictly in accordance with the terms outlined in the agreement.

These newly issued convertible bonds are convertible into the company's H-shares at an initial conversion price of HK$36.08 per share. This conversion price is subject to potential adjustments as per the standard terms of such instruments.